VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CDT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CDTCDT Equity Inc.
$0.44$17334
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

CDT logoCDT Equity Inc.(CDT)Earnings, Financials & Key Ratios

CDT•NASDAQ
$0.44
Price updated Jul 7, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryRoyalty and IP Monetization Vehicles
AboutCDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.Show more
  • Revenue$0
  • EBITDA-$34M-129.5%
  • Net Income-$39M-120.3%
  • EPS (Diluted)-1177.90+98.1%
  • ROE-6.24%

CDT Price & Volume

CDT Equity Inc. (CDT) stock price & volume — 10-year historical chart

Loading chart...

Revenue Inflection Masks Significant Cash Flow Volatility

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Accelerating
Profitability:Moderate
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Binary clinical asset failure

Key Thesis Takeaways

  • CDT Equity has successfully transitioned from a dormant development entity to a commercial-stage biotechnology firm, evidenced by its inaugural $696.4 million revenue print in 2026Q1.
  • While the company has achieved a positive net income of $51.0 million and reversed its historical equity deficit to $1.3 billion, the sustainability of this growth remains uncertain due to lumpy clinical asset commercialization.
  • Investors should monitor the divergence between accounting profitability and the $18.7 million operating cash flow deficit, alongside the potential dilutionary impact of $9.2 million in quarterly stock-based compensation.

Verdict Logic

while the company has achieved a 11.2% operating margin, the aggressive $30.4 million share repurchase program during a period of negative $18.7 million operating cash flow warrants caution regarding capital allocation priorities.

CDT Growth Metrics

CDT Equity Inc. (CDT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM187.12%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM99.33%

Return on Capital

10 Years-5410.63%
5 Years-5410.63%
3 Years-421.58%
Last Year-2.59%

CDT Recent Earnings

CDT Equity Inc. (CDT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
Q3 2026Latest
Jun 25, 2026
Metric
Actual
Est
EPS
$13.10
—
Rev
$696M
—
Q3 2026
Jun 11, 2026
Metric
Actual
Est
EPS
$13.10
—
Rev
$696M
—
Q3 2026
Jun 4, 2026
Metric
Actual
Est
EPS
$13.10
—
Rev
$696M
—
Q2 2026
May 28, 2026
Metric
Actual
Est
EPS
$13.10
—
Rev
$696M
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026LatestJun 25, 2026
$13.10
$696M
Q3 2026Jun 11, 2026
$13.10
$696M
Q3 2026Jun 4, 2026
$13.10
$696M
Q2 2026May 28, 2026
$13.10
$696M
Based on last 12 quarters of dataView full earnings history →

Latest CDT News

Recent stock market news and headlines for CDT Equity Inc. (CDT)

GlobeNewsWire·1 day ago
CDT Environmental Technology Investment Holdings Regains Compliance with Nasdaq Minimum Bid Price Requirement

SHENZHEN, China, July 07, 2026 (GLOBE NEWSWIRE) -- CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) (the “Company” or “CDT”), a leading provider of waste treatment systems and services throughout China, today announced that it received on June 30, 2026 a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities, including the Company's ordinary shares, to maintain a minimum bid price of $1.00 per share. The staff of Nasdaq's Listing Qualifications Department made this determination of compliance after the closing bid price of the Company's ordinary shares was at $1.00 per share or greater for the 10 consecutive business days prior to the date of the notice.

GlobeNewsWire·2 days ago
CDT Environmental Technology Investment Holdings Limited to Hold Extraordinary General Meeting on July 28, 2026

SHENZHEN, China, July 06, 2026 (GLOBE NEWSWIRE) -- CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) (the “Company” or “CDT”), a leading provider of waste treatment systems and services throughout China, announced that it will hold an Extraordinary General Meeting of Shareholders (the “EGM”) virtually by electronic means on Tuesday, the 28th day of July 2026, commencing at 9:30 a.m. (Beijing Time).

GlobeNewsWire·Jun 26, 2026
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development

NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the expansion of its Signature Intelligence platform into quantum-assisted coformer selection through SarborgQ, the Company's dedicated quantum computing division.

Benzinga·Jun 18, 2026
CDT Equity Stock Gets A Boost On SarborgQ Development News

CDT Equity Inc. (NASDAQ:CDT) shares are soaring Thursday after the company highlighted a new fundraising round completed by Sarborg Limited, a firm in which CDT holds 1,020 shares. The proceeds will support the launch of SarborgQ.

GlobeNewsWire·Jun 18, 2026
CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding its recent fundraise from a New York-based private investment fund.

Peers Comparison

Key metrics vs top competitors for CDT Equity Inc. (CDT)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CDT logoCDTCDT Equity Inc.Current
$0.44$17.33K-0.00——-6.24%—
CSWC logoCSWCCapital Southwest Corporation
$23.51$1.46B12.3750.13%50.89%11.68%—
TPVG logoTPVGTriplePoint Venture Growth BDC Corp.
$4.75$192.85M3.8936.55%-19.55%-3.39%—
GAIN logoGAINGladstone Investment Corporation
$15.64$622.82M3.28-20.47%173.56%34.04%—
MRCC logoMRCCMonroe Capital Corporation
$5.08$110.06M9.58-39.74%-72.87%-2.9%—
HRZN logoHRZNHorizon Technology Finance Corporation
$4.64$204.76M4.4217.91%37.39%8.95%—

Compare CDT vs Peers

CDT Equity Inc. (CDT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CSWC

Most directly comparable listed peer for CDT.

Scale Benchmark

vs BX

Larger-name benchmark to compare CDT against a more recognizable public peer.

Peer Set

Compare Top 5

vs CSWC, TPVG, GAIN, MRCC

CDT SEC Filings & Documents

CDT Equity Inc. (CDT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Jul 1, 2026·SEC

Material company update

Jun 29, 2026·SEC

Material company update

Jun 16, 2026·SEC

10-K Annual Reports

3
FY 2026

Apr 15, 2026·SEC

FY 2026

Feb 17, 2026·SEC

FY 2025

Mar 28, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 30, 2026·SEC

FY 2025

Nov 13, 2025·SEC

FY 2025

Oct 30, 2025·SEC

Get notified when CDT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CDT Frequently Asked Questions

CDT Equity Inc. (CDT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is CDT Equity Inc.'s revenue?

CDT Equity Inc. (CDT) reported $696.4M in revenue for fiscal year 2025.

Is CDT profitable?

Yes, CDT Equity Inc. (CDT) is profitable, generating $16.6M in net income for fiscal year 2025 (2.4% net margin).

Dividend & Returns
What is CDT's return on equity?

CDT Equity Inc. (CDT) has a return on equity (ROE) of -6.2%. Negative ROE indicates the company is unprofitable.

What is CDT Equity Inc.'s free cash flow?

CDT Equity Inc. (CDT) had negative free cash flow of $6.0M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in CDT back in 2021?

Total return calculator · dividends reinvested · 5+ years of data

See returns →